Clinical observation of lisinopril in treating primary hypertension in aged
Junlin Zhang
Abstract
Junlin Zhang
Abstract
Objective To compare the clinical efficacies and safety of lisinopril and captopril. Methods Lisinopril group of 31 patients (M 27, F 4; age 68±6a) received lisinopril 10-30mg, po, qd for 4wk. The controll group of 28 patients (M 25, F 3; age 67±7a ) received captopril 12.5-25mg, po, bid or tid for 4 wk. Results The total response rates of lisinopril group and captopril group were 93.6%and 89.3%(P0.05). There were no significant differences(P0.05) between 2 groups in the hypotensive effect. The side effects of 2 groups were mild. Conclusion Lisinopril is effective and safe in treating primary hypertension in aged patients. The side effect of lisinopril is mild.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To compare the clinical efficacies and safety of lisinopril and captopril. Methods Lisinopril group of 31 patients (M 27, F 4; age 68±6a) received lisinopril 10-30mg, po, qd for 4wk. The controll group of 28 patients (M 25, F 3; age 67±7a ) received captopril 12.5-25mg, po, bid or tid for 4 wk. Results The total response rates of lisinopril group and captopril group were 93.6%and 89.3%(P0.05). There were no significant differences(P0.05) between 2 groups in the hypotensive effect. The side effects of 2 groups were mild. Conclusion Lisinopril is effective and safe in treating primary hypertension in aged patients. The side effect of lisinopril is mild.
Key concepts: Lisinopril, Captopril, Medicine, Urology, Side effect (computer science), Pharmacology, Internal medicine, Gastroenterology